Greg Towers
Greg Towers
Verifisert e-postadresse på ucl.ac.uk
Sitert av
Sitert av
Positional cloning of the mouse retrovirus restriction gene Fvl
S Best, PL Tissier, G Towers, JP Stoye
Nature 382 (6594), 826-829, 1996
HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency
T Schaller, KE Ocwieja, J Rasaiyaah, AJ Price, TL Brady, SL Roth, S Hué, ...
PLoS pathogens 7 (12), e1002439, 2011
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
GJ Towers, T Hatziioannou, S Cowan, SP Goff, J Luban, PD Bieniasz
Nature medicine 9 (9), 1138-1143, 2003
HIV-1 evades innate immune recognition through specific cofactor recruitment
J Rasaiyaah, CP Tan, AJ Fletcher, AJ Price, C Blondeau, L Hilditch, ...
Nature 503 (7476), 402-405, 2013
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)
DL Mallery, WA McEwan, SR Bidgood, GJ Towers, CM Johnson, ...
Proceedings of the National Academy of Sciences 107 (46), 19985-19990, 2010
The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities
Z Keckesova, LMJ Ylinen, GJ Towers
Proceedings of the National Academy of Sciences 101 (29), 10780-10785, 2004
Restriction of lentivirus in monkeys
C Besnier, Y Takeuchi, G Towers
Proceedings of the National Academy of Sciences 99 (18), 11920-11925, 2002
A conserved mechanism of retrovirus restriction in mammals
G Towers, M Bock, S Martin, Y Takeuchi, JP Stoye, O Danos
Proceedings of the National Academy of Sciences 97 (22), 12295-12299, 2000
Restriction of multiple divergent retroviruses by Lv1 and Ref1
T Hatziioannou, S Cowan, SP Goff, PD Bieniasz, GJ Towers
The EMBO journal 22 (3), 385-394, 2003
The control of viral infection by tripartite motif proteins and cyclophilin A
GJ Towers
Retrovirology 4, 1-10, 2007
CPSF6 defines a conserved capsid interface that modulates HIV-1 replication
AJ Price, AJ Fletcher, T Schaller, T Elliott, KE Lee, VN KewalRamani, ...
Public Library of Science 8 (8), e1002896, 2012
Independent evolution of an antiviral TRIMCyp in rhesus macaques
SJ Wilson, BLJ Webb, LMJ Ylinen, E Verschoor, JL Heeney, GJ Towers
Proceedings of the National Academy of Sciences 105 (9), 3557-3562, 2008
HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2
KE Ocwieja, TL Brady, K Ronen, A Huegel, SL Roth, T Schaller, ...
PLoS pathogens 7 (3), e1001313, 2011
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation
A Di Pietro, A Kajaste-Rudnitski, A Oteiza, L Nicora, GJ Towers, N Mechti, ...
Journal of virology 87 (8), 4523-4533, 2013
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion
RK Gupta, S Hué, T Schaller, E Verschoor, D Pillay, GJ Towers
PLoS pathogens 5 (5), e1000443, 2009
Disease-associated XMRV sequences are consistent with laboratory contamination
S Hué, ER Gray, A Gall, A Katzourakis, CP Tan, CJ Houldcroft, S McLaren, ...
Retrovirology 7 (1), 1-10, 2010
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis
DA Jacques, WA McEwan, L Hilditch, AJ Price, GJ Towers, LC James
Nature 536 (7616), 349-353, 2016
Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5α alleles
LMJ Ylinen, Z Keckesova, SJ Wilson, S Ranasinghe, GJ Towers
Journal of virology 79 (18), 11580-11587, 2005
Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration
RK Gupta, P Mlcochova, A Pelchen-Matthews, SJ Petit, G Mattiuzzo, ...
Proceedings of the National Academy of Sciences 106 (49), 20889-20894, 2009
The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin
C Pardieu, R Vigan, SJ Wilson, A Calvi, T Zang, P Bieniasz, P Kellam, ...
PLoS pathogens 6 (4), e1000843, 2010
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20